Suppr超能文献

一种在万向旋转线性加速器系统上进行肿瘤跟踪的互补双模验证方法。

A complementary dual-modality verification for tumor tracking on a gimbaled linac system.

机构信息

Department of Radiotherapy, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Belgium.

出版信息

Radiother Oncol. 2013 Dec;109(3):469-74. doi: 10.1016/j.radonc.2013.10.005. Epub 2013 Nov 14.

Abstract

BACKGROUND AND PURPOSE

For dynamic tracking of moving tumors, robust intra-fraction verification was required, to assure that tumor motion was properly managed during the course of radiotherapy. A dual-modality verification system, consisting of an on-board orthogonal kV and planar MV imaging device, was validated and applied retrospectively to patient data.

METHODS AND MATERIALS

Real-time tumor tracking (RTTT) was managed by applying PAN and TILT angular corrections to the therapeutic beam using a gimbaled linac. In this study, orthogonal X-ray imaging and MV EPID fluoroscopy was acquired simultaneously. The tracking beam position was derived from respectively real-time gimbals log files and the detected field outline on EPID. For both imaging modalities, the moving target was localized by detection of an implanted fiducial. The dual-modality tracking verification was validated against a high-precision optical camera in phantom experiments and applied to clinical tracking data from a liver and two lung cancer patients.

RESULTS

Both verification modalities showed a high accuracy (<0.3mm) during validation on phantom. Marker detection on EPID was influenced by low image contrast. For the clinical cases, gimbaled tracking showed a 90th percentile error (E90) of 3.45 (liver), 2.44 (lung A) and 3.40 mm (lung B) based on EPID fluoroscopy and good agreement with XR-log file data by an E90 of 3.13, 1.92 and 3.33 mm, respectively, during beam on.

CONCLUSION

Dual-modality verification was successfully implemented, offering the possibility of detailed reporting on RTTT performance.

摘要

背景与目的

为了对移动肿瘤进行动态跟踪,需要进行稳健的分次内验证,以确保在放射治疗过程中对肿瘤运动进行适当的管理。我们验证并回顾性地将一种由机载正交千伏(kV)和平面兆伏(MV)成像设备组成的双模验证系统应用于患者数据。

方法和材料

通过使用安装在万向架上的直线加速器对治疗束施加 PAN 和 TILT 角度校正,实现实时肿瘤跟踪(RTTT)。在这项研究中,我们同时采集正交 X 射线成像和 MV EPID 荧光透视图像。跟踪束位置源自实时万向架日志文件和 EPID 上检测到的射野轮廓。对于这两种成像模式,通过检测植入的基准标记来定位移动目标。我们在体模实验中验证了双模跟踪验证系统,并将其应用于来自肝脏和两个肺癌患者的临床跟踪数据。

结果

在体模验证中,两种验证模式均显示出高精度(<0.3mm)。EPID 上的标记检测受到低图像对比度的影响。对于临床病例,基于 EPID 荧光透视的万向架跟踪显示 90 百分位误差(E90)分别为 3.45(肝脏)、2.44(肺 A)和 3.40 毫米(肺 B),与束流开启时的 XR-log 文件数据吻合良好,E90 分别为 3.13、1.92 和 3.33 毫米。

结论

成功实施了双模验证,为 RTTT 性能的详细报告提供了可能性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验